Skip to main content
FinSpry Logo
FinSpry
ESPR logo
ESPR
(NASDAQ)
Esperion Therapeutics, Inc.
$3.15-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Esperion Therapeutics (ESPR) Stock Price & Financial Analysis

Esperion Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.13 - $3.16
52-Week High$4.18
52-Week Low$0.95
Open$3.15
Volume10.80M
Average Volume (3M)10.16M
Market Cap791.76M
Shares Outstanding251.35M
Price to Sales (P/S)1.89
Price to Book (P/B)-2.57
EV/EBITDA29.02
Revenue (TTM)418.24M
Net Income (TTM)-7.42M
Free Cash Flow (TTM)-18.19M
EPS (TTM)$-0.03
Profit Margin-1.77%
Operating Margin18.12%
50-Day MA$2.84
200-Day MA$3.03
52-Week Change194.39%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Esperion Therapeutics

What is the current stock price for ESPR?

As of the latest trading session, ESPR stock trades at $3.15. The 52-week range is $0.95–$4.18, with a day range of $3.13–$3.16.

What is the P/E ratio for ESPR?

The P/E ratio (Price-to-Earnings) for ESPR is shown in the Key Statistics section. This valuation metric helps compare Esperion Therapeutics, Inc. to industry peers.

Does ESPR pay dividends?

Esperion Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ESPR?

Based on 6 analysts, the consensus for ESPR is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ESPR?

Esperion Therapeutics's market capitalization is $791.8M, classifying it as a small-cap company. Esperion Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.